Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
55.60
+1.90 (3.54%)
At close: May 22, 2026

STO:IBT.B Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
131.93144.01223.39329.06335.84386.75
Cash & Short-Term Investments
131.93144.01223.39329.06335.84386.75
Cash Growth
-31.20%-35.53%-32.11%-2.02%-13.16%-8.66%
Other Receivables
1.583.394.776.741.781.2
Receivables
1.583.394.776.741.781.2
Prepaid Expenses
1.676.212.465.761.419.14
Other Current Assets
-0-00-0-
Total Current Assets
135.18153.61230.61341.56339.03397.09
Long-Term Investments
0.070.070.070.070.070.05
Long-Term Deferred Charges
7.878.078.899.710.5211.33
Other Long-Term Assets
----0--
Total Assets
143.11161.75239.57351.33349.62408.48
Accounts Payable
46.4343.8646.9930.078.754.8
Accrued Expenses
13.7212.1721.8915.338.677.65
Other Current Liabilities
0.390.390.420.780.50.78
Total Current Liabilities
60.5456.4269.346.1817.9113.22
Other Long-Term Liabilities
----0-
Total Liabilities
60.5456.4269.346.1817.9113.22
Common Stock
3.673.673.673.673.063.06
Additional Paid-In Capital
768.84768.84768.84766.83670.93669.02
Retained Earnings
-689.94-667.18-602.25-465.35-342.28-276.83
Comprehensive Income & Other
--0-0-0-
Shareholders' Equity
82.58105.33170.26305.15331.71395.25
Total Liabilities & Equity
143.11161.75239.57351.33349.62408.48
Net Cash (Debt)
131.93144.01223.39329.06335.84386.75
Net Cash Growth
-31.20%-35.53%-32.11%-2.02%-13.16%-8.66%
Net Cash Per Share
9.7910.6916.5826.6129.9234.45
Filing Date Shares Outstanding
13.4713.4713.4713.4711.2311.23
Total Common Shares Outstanding
13.4713.4713.4713.4711.2311.23
Working Capital
74.6497.19161.31295.38321.12383.87
Book Value Per Share
6.137.8212.6422.6529.5535.21
Tangible Book Value
82.58105.33170.26305.15331.71395.25
Tangible Book Value Per Share
6.137.8212.6422.6529.5535.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.